I do like the fact that the new critical trial will have an interim look at 40% . Figure the patient number out and look back remembering the number the US FDA mentioned they needed for analysis to validate and get to a P value . Coincidence . If good results from the 40% interim . Is it possible the FDA will combine and move on the total results ??????